Iterum Therapeutics plc (ITRMF) Times Interest Earned (2024 - 2025)
Iterum Therapeutics (ITRMF) posted Times Interest Earned of 13.76 for Q3 2025, down 11.71% on a QoQ basis from 12.31 in Q2 2025, and down 112.8% year-over-year from 107.44 in Q3 2024.
Powered by 
Analysis
Iterum Therapeutics plc (ITRMF) Times Interest Earned (2024 - 2025) Analysis & Trends
Iterum Therapeutics has reported Times Interest Earned for 2 years, with the latest figure at 13.76 in Q3 2025.
- On a quarterly basis, Times Interest Earned fell 112.8% year-over-year to 13.76 in Q3 2025; TTM through Sep 2025 was 7.5, a N/A change from a year earlier, with the FY2024 full-year figure at 5.65, up 62.53% from the prior year.
- Times Interest Earned was 13.76 for Q3 2025 at Iterum Therapeutics, down from 12.31 in the prior quarter.
- The five-year high for Times Interest Earned was 3.48 in Q4 2024, with the low at 13.76 in Q3 2025.
Peer Set
Peer Comparison
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2025 | -13.76 |
| Jun 30, 2025 | -12.31 |
| Mar 31, 2025 | -5.41 |
| Dec 31, 2024 | -3.48 |
| Sep 30, 2024 | -6.46 |
| Jun 30, 2024 | -5.30 |
| Mar 31, 2024 | -8.23 |